Intercept Pharmaceuticals, Inc.

RENAISSANCE TECHNOLOGIES LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

825,800

Value ($000)

15,310

Weight

0.0%

2014 Q1 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	15,310	0.0%	825,800	9/30/2023
2023 Q2	8/11/2023	9,726	0.0%	879,400	6/30/2023
2023 Q1	5/12/2023	14,104	0.0%	1,050,200	3/31/2023
2022 Q4	2/13/2023	8,762	0.0%	708,300	12/31/2022
2022 Q3	11/14/2022	10,312	0.0%	739,200	9/30/2022
2022 Q2	8/12/2022	5,433	0.0%	393,400	6/30/2022
2022 Q1	5/13/2022	3,501	0.0%	215,200	3/31/2022
2021 Q4	2/11/2022	3,968	0.0%	243,569	12/31/2021
2021 Q3	11/12/2021	2,964	0.0%	199,600	9/30/2021
2021 Q1	5/13/2021	822	0.0%	35,600	3/31/2021
2020 Q4	2/10/2021	10,794	0.0%	437,000	12/31/2020
2020 Q3	11/13/2020	10,145	0.0%	244,700	9/30/2020
2020 Q2	8/13/2020	15,341	0.0%	320,200	6/30/2020
2020 Q1	5/14/2020	19,291	0.0%	306,400	3/31/2020
2019 Q4	2/13/2020	11,425	0.0%	92,200	12/31/2019
2014 Q1	5/14/2014	2,144	0.0%	6,500	3/31/2014